Ryo Naito

Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists

Ryo Naito, Yasuhiro Yonetoku, Yoshinori Okamoto et al. · Journal of Medicinal Chemistry · 2005 · 153 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Synthetic studies on novel Syk inhibitors. Part 1: Synthesis and structure–activity relationships of pyrimidine-5-carboxamide derivatives

Hiroyuki Hisamichi, Ryo Naito, Akira Toyoshima et al. · Bioorganic & Medicinal Chemistry · 2005 · 54 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo

Satoshi Yamamoto, Shingo Sugahara, Ryo Naito et al. · European Journal of Pharmacology · 2006 · 25 citations

Life Sciences, Immunology, Pharmacology +16

Synthesis and Pharmacological Characterization of Novel 6-Fluorochroman Derivatives as Potential 5-HT_1A Receptor Antagonists

Tomoyuki Yasunaga, Takenori Kimura, Ryo Naito et al. · Journal of Medicinal Chemistry · 1998 · 24 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

<i>N</i>-[2-[(Substituted chroman-8-yl)oxy]ethyl]-4-(4-methoxyphenyl)butylamines:  Synthesis and Wide Range of Antagonism at the Human 5-HT_1A Receptor

Tomoyuki Yasunaga, Ryo Naito, Toru Kontani et al. · Journal of Medicinal Chemistry · 1997 · 13 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17